Skip to main content

previous disabled Page of 221
and
  1. Article

    Getting stuck in

    Melanie Brazil in Nature Reviews Drug Discovery (2002)

  2. Article

    Model behaviour...

    Clare Ellis in Nature Reviews Drug Discovery (2002)

  3. No Access

    Article

    Emerging immune targets for the therapy of allergic asthma

  4. Despite the existence of effective therapies, allergic asthma and related atopic syndromes have recently emerged as epidemic diseases and important public heal...

  5. David B. Corry in Nature Reviews Drug Discovery (2002)

  6. No Access

    Article

    Drug discovery by dynamic combinatorial libraries

  7. Dynamic combinatorial chemistry is a supramolecular approach that uses a self-assembly process to generate libraries of chemical compounds. Spontaneous assembl...

  8. Olof Ramström, Jean-Marie Lehn in Nature Reviews Drug Discovery (2002)

  9. No Access

    Article

    High-throughput crystallography for lead discovery in drug design

  10. Knowledge of the three-dimensional structures of target proteins provides a starting point for structure-based approaches to drug design by defining the topogr...

  11. Tom L. Blundell, Harren Jhoti, Chris Abell in Nature Reviews Drug Discovery (2002)

  12. No Access

    Article

    Toxicogenomics and drug discovery: will new technologies help us produce better drugs?

    Acting on reports in the late 1980s that most drug candidates fail in development, pharmaceutical discovery programmes responded by devising ways to increase the number of chemicals in the pipeline. With disco...

    Roger Ulrich, Stephen H. Friend in Nature Reviews Drug Discovery (2002)

  13. No Access

    Article

    Targeting glycosylation as a therapeutic approach

  14. Protein and lipid glycosylation are vital to fundamental cellular processes. For therapeutic strategies that target glycosylation, modulation rather than ablat...

  15. Raymond A. Dwek, Terry D. Butters, Frances M. Platt in Nature Reviews Drug Discovery (2002)

  16. Article

    In this issue

    Adam Smith, Melanie Brazil, Peter Kirkpatrick in Nature Reviews Drug Discovery (2002)

  17. Article

    What's your poison?

    Adam Smith in Nature Reviews Drug Discovery (2002)

  18. Article

    eSCA** high cholesterol

    Adam Smith in Nature Reviews Drug Discovery (2002)

  19. Article

    First class delivery

    Melanie Brazil in Nature Reviews Drug Discovery (2002)

  20. No Access

    Article

    ...And fashionable screening

    Melanie Brazil in Nature Reviews Drug Discovery (2002)

  21. No Access

    Article

    Strategies in the design of antiviral drugs

  22. Greater understanding of viral life cycles has resulted in the discovery and validation of several targets for therapeutic intervention, and an increase in the...

  23. Erik De Clercq in Nature Reviews Drug Discovery (2002)

  24. No Access

    Article

    The genetic basis of variability in drug responses

  25. Variability in response to therapy is an expected feature of most drug treatments.

  26. Pharmacokinetic variabil...

  27. Dan M. Roden, Alfred L. George Jr in Nature Reviews Drug Discovery (2002)

  28. No Access

    Article

    Moving smaller in drug discovery and delivery

    Advances in new micro- and nanotechnologies are accelerating the identification and evaluation of drug candidates, and the development of new delivery technologies that are required to transform biological pot...

    David A. LaVan, David M. Lynn, Robert Langer in Nature Reviews Drug Discovery (2002)

  29. Article

    Cheek to cheek

    Peter Kirkpatrick in Nature Reviews Drug Discovery (2002)

  30. No Access

    Article

    Antiviral market overview

    David Milroy, James Featherstone in Nature Reviews Drug Discovery (2002)

  31. Article

    Insulin in disguise

    Peter Kirkpatrick in Nature Reviews Drug Discovery (2002)

  32. No Access

    Article

    The potential for novel anti-inflammatory therapies for coronary artery disease

  33. Although drugs that lead to cholesterol and lipid lowering have proved to have significant effects in lowering cardiovascular morbidity and mortality, coronary...

  34. Margaret A. Cascieri in Nature Reviews Drug Discovery (2002)

  35. No Access

    Article

    Drug and gene targeting to the brain with molecular trojan horses

  36. The brains of all vertebrates are protected from substances in the blood by the blood–brain barrier (BBB). Although the BBB maintains brain function under norm...

  37. William M. Pardridge in Nature Reviews Drug Discovery (2002)

previous disabled Page of 221